Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
VTYX
Stock Latest News
Company Announcements
Ventyx Biosciences Reports Decreased Losses in 2025
3d ago
VTYX
Premium
Market News
3 Best Stocks to Buy Now, 8/11/2025, According to Top Analysts
6d ago
BLZE
UBER
Premium
Ratings
Promising Developments at Ventyx Biosciences Justify Buy Rating
9d ago
VTYX
Premium
Ratings
Hold Rating for Ventyx Biosciences Amid Promising Early Data and Strategic Uncertainties
2M ago
VTYX
Premium
Ratings
Positive Outlook on Ventyx Biosciences Due to Promising Developments in Neuro-Inflammatory Treatments
2M ago
VTYX
Premium
Ratings
Positive Buy Rating for Ventyx Biosciences Driven by Promising Phase 2a Trial Results and Strong Financial Position
2M ago
VTYX
Premium
Company Announcements
Ventyx Biosciences Announces Positive Phase 2a Trial Results
2M ago
8K
VTYX
Premium
The Fly
Ventyx announces Phase 2a study of VTX3232 accomplished primary objective
2M ago
VTYX
Premium
The Fly
Ventyx Biosciences halted, news pending
2M ago
VTYX
Premium
Company Announcements
Ventyx Biosciences Holds Annual Stockholders Meeting
2M ago
8K
VTYX
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
TIL
IMNN
Premium
Ratings
Ventyx Biosciences: Strategic Investment by Sanofi Highlights Promising Prospects and Innovative Approach
3M ago
VTYX
Premium
Ratings
Buy Rating for Ventyx Biosciences: Promising Clinical Trials and Strong Financial Position
3M ago
VTYX
Premium
Ratings
Ventyx Biosciences: Promising Pipeline and Upcoming Data Readouts Justify Buy Rating
3M ago
VTYX
Premium
Company Announcements
Ventyx Biosciences Reports Q1 2025 Financial Results
3M ago
VTYX
Premium
The Fly
Ventyx Biosciences reports Q1 EPS (39c), consensus (48c)
3M ago
VTYX
Premium
The Fly
Ventyx Biosciences announces seven additional appointments to SAB
5M ago
VTYX
Premium
Company Announcements
Ventyx Biosciences Reports 2024 Financial Results and Progress
6M ago
VTYX
Premium
Company Announcements
Ventyx Biosciences Faces Supply Chain Risks Amidst U.S.-China Tensions and Regulatory Challenges
6M ago
VTYX
Premium
The Fly
Ventyx Biosciences reports Q4 EPS (41c), consensus (55c)
6M ago
VTYX
Premium
The Fly
Ventyx Biosciences’ VTX958 shows efficacy in Crohn’s Disease
6M ago
VTYX
Premium
The Fly
Ventyx’s Phase 2 programs ‘high risk/high reward,’ says H.C. Wainwright
7M ago
VTYX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
